Gabapentin Sales Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, GSK, Sailike, Jiangsu Enhua, Jiangsu Hengrui, Novartis, Actavis, Glenmark. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The scope of the report includes a detailed study of global and regional markets on Nasal Spray Marketwith the reasons given for variations in the growth of the industry in certain regions.

Gabapentin sales are usually done under the brand names Neuron tin, and are also available as generic drugs. It is known as an anti-epileptic medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy it may be used to affect the chemicals and nerves in the body that are involved in the cause of partial seizures and some types of pain. The Horizant brand of gabapentin is also used to treat restless legs syndrome (RLS).

You Can Browse Full Report:

This report provides:

1) An overview of the global market for gabapentin sales and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for global gabapentin sales market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of global gabapentin sales market are as follows:

  • Gabapentin is available as both a generic and brand-name drug.
  • It is used in various treatments such as seizures, post herpetic neuralgia, restless legs syndrome.

The restraining factors of global gabapentin sales marketare as follows:

  • There is fear of side effects like sleepiness, fatigue, vomiting etc.
  • It can also cause serious problems like memory loss, weight gain, join pain etc.

The global gabapentin sales market has been segmented as below:

The global Gabapentin sales market is Segmented on the lines of Product Type Analysis, End users and Regional Analysis. By Product Type Analysis this market is segmented on the basis of Tablet and Capsule.

By End users this market is segmented on the basis of Nerve pain sector, Restless legs syndrome sector and Seizures sector. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

Request Sample Report:

Table of Contents


2 Manufacturers Profiles

3 Global Gabapentin Market Competition, by Manufacturer

4 Global Gabapentin Market Analysis by Regions

5 North America Gabapentin by Countries

6 Europe Gabapentin by Countries

7 Asia-Pacific Gabapentin by Countries

8 South America, Middle East and Africa Gabapentin by Countries

9 Gabapentin Market Segment by Type

10 Gabapentin Market Segment by Application

11 Gabapentin Market Forecast

11.1 Global Gabapentin Sales, Revenue and Growth Rate

11.2 Gabapentin Market Forecast by Regions

11.3 Gabapentin Market Forecast by Type

11.4 Gabapentin Market Forecast by Application

12 Sales Channel, Distributors, Traders and Dealers

13 Company Profile

13.1 Pfizer

13.2 GSK

13.3 Sailike

13.4 Jiangsu Enhua

13.5 Jiangsu Hengrui

13.6 Novartis

13.7 Actavis

13.7 Glenmark

Other Related Market Research Reports:

Gas Chromatography Market is Supposed to Reach US$ 3.50 Billion By 2022

Gemfibrozil Sales Market Scope, Size, Share, Analysis by 2022

Healthcare Biomarkers Market is Supposed to Reach US$ 56 Billion By 2022

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States